CORE TECHNOLOGY PLATFORM
CORE TECHNOLOGY PLATFORM
Existing commercialised diagnostic catheter system can be selected in greater than 300 different ways to suit different clinical preference and patient needs.
Integrates with existing hospital 3D-mapping systems and clinical workflows, including fluoroscopy-based imaging, allowing clinicians to adopt it without changing current equipment or procedural routines.
In the event the distal loop catheter is entangled within the cardiac structures, the inner stylet can be withdrawn from the outer catheter sheath, reducing the stiffness in the distal loop and the force required to free the loop.

Flexible, hollow tubes designed to navigate through the body’s vessels or cavities. They carry electrical signals from the electrodes to the EP equipment.

Thin, wire-like tools inserted into catheter tubes to provide directional control. By adjusting the stylet, clinicians can guide the catheter through complex anatomical pathways with precision.

Ergonomic control handles are attached to the catheter tube and steering stylet. They allow operators to steer, rotate, or actuate features of the catheter, enhancing maneuverability and procedural control.

Complete catheter assemblies that include the catheter tube, steering stylet, and control handle. These integrated systems are designed for diagnostic or therapeutic procedures, offering precise navigation and control within the body.
CathRx’s PFA portfolio consists of 8F catheter, among the smallest on the market, designed to reduce the risk of perforation while enhancing procedural safety and efficiency.
ElectroPulse PFA catheters can be used for both diagnostic and therapeutic functionality. This reduced the need for a separate mapping catheter, which may reduce procedural costs.
CathRx’s generator delivers a high-voltage output of 2800V without compromising on patient safety.
This feature provides EPs with real time feedback to ensure optimal contact with the target tissue before energy delivery, ensuring ideal catheter positioning before applying therapy.
The ElectroPulse PFA Catheter range includes both circular and linear catheters, providing versatility to accommodate a variety of procedural needs.
The ElectroPulse catheters are based on the proven cost effective Khelix diagnostic catheter platform. ElectroPulse catheters are easy to manufacture and cost effective.
PFA uses high-voltage, ultra-short electrical pulses (non-thermal energy) to create lesions around the pulmonary veins, selectively targeting cardiac cells while sparing nearby critical structures such as the oesophagus, phrenic nerve, and blood vessels.
Because PFA’s mechanism is electroporation (not heat), it significantly reduces the risk of injury to surrounding tissues (e.g., oesophagus, nerves, veins) compared to conventional radiofrequency or cryoablation.
The procedure achieves durable pulmonary vein isolation in a matter of seconds per vein, offering a faster workflow and potentially shorter procedure times than thermal ablation techniques.
Early clinical studies and registries show that PFA provides high rates of durable pulmonary vein isolation with low complication rates, making it a promising and safer alternative to conventional ablation for atrial fibrillation.